Altered manganese homeostasis and manganese toxicity in a huntington's disease striatal cell model are not explained by defects in the iron transport system

B. Blairanne Williams, Gunnar F. Kwakye, Michal Wegrzynowicz, Daphne Li, Michael Aschner, Keith M. Erikson, Aaron B. Bowman

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Expansion of a polyglutamine tract in Huntingtin (Htt) leads to the degeneration of medium spiny neurons in Huntington's disease (HD). Furthermore, the HTT gene has been functionally linked to iron (Fe) metabolism, and HD patients show alterations in brain and peripheral Fe homeostasis. Recently, we discovered that expression of mutant HTT is associated with impaired manganese (Mn) uptake following overexposure in a striatal neuronal cell line and mouse model of HD. Here we test the hypothesis that the transferrin receptor (TfR)-mediated Fe uptake pathway is responsible for the HD-associated defects in Mn uptake. Western blot analysis showed that TfR levels are reduced in the mutant STHdhQ111/Q111 striatal cell line, whereas levels of the Fe and Mn transporter, divalent metal transporter 1 (DMT1), are unchanged. To stress the Fe transport system, we exposed mutant and wild-type cells to elevated Fe(III), which revealed a subtle impairment in net Fe uptake only at the highest Fe exposures. In contrast, the HD mutant line exhibited substantial deficits in net Mn uptake, even under basal conditions. Finally, to functionally evaluate a role for Fe transporters in the Mn uptake deficit, we examined Mn toxicity in the presence of saturating Fe(III) levels. Although Fe(III) exposure decreased Mn neurotoxicity, it did so equally for wild-type and mutant cells. Therefore, although Fe transporters contribute to Mn uptake and toxicity in the striatal cell lines, functional alterations in this pathway are insufficient to explain the strong Mn resistance phenotype of this HD cell model.

Original languageEnglish (US)
Pages (from-to)169-179
Number of pages11
JournalToxicological Sciences
Volume117
Issue number1
DOIs
StatePublished - Jun 13 2010
Externally publishedYes

Fingerprint

Corpus Striatum
Huntington Disease
Manganese
Toxicity
Homeostasis
Iron
Defects
Transferrin Receptors
Cells
Cell Line
Metabolism
Neurons
Brain
Genes
Western Blotting
Phenotype

Keywords

  • Huntington's disease
  • Iron
  • Manganese
  • Neurotoxicity
  • Transferrin receptor

ASJC Scopus subject areas

  • Toxicology

Cite this

Altered manganese homeostasis and manganese toxicity in a huntington's disease striatal cell model are not explained by defects in the iron transport system. / Williams, B. Blairanne; Kwakye, Gunnar F.; Wegrzynowicz, Michal; Li, Daphne; Aschner, Michael; Erikson, Keith M.; Bowman, Aaron B.

In: Toxicological Sciences, Vol. 117, No. 1, 13.06.2010, p. 169-179.

Research output: Contribution to journalArticle

Williams, B. Blairanne ; Kwakye, Gunnar F. ; Wegrzynowicz, Michal ; Li, Daphne ; Aschner, Michael ; Erikson, Keith M. ; Bowman, Aaron B. / Altered manganese homeostasis and manganese toxicity in a huntington's disease striatal cell model are not explained by defects in the iron transport system. In: Toxicological Sciences. 2010 ; Vol. 117, No. 1. pp. 169-179.
@article{334a50f584034fdeba3fe21e51545121,
title = "Altered manganese homeostasis and manganese toxicity in a huntington's disease striatal cell model are not explained by defects in the iron transport system",
abstract = "Expansion of a polyglutamine tract in Huntingtin (Htt) leads to the degeneration of medium spiny neurons in Huntington's disease (HD). Furthermore, the HTT gene has been functionally linked to iron (Fe) metabolism, and HD patients show alterations in brain and peripheral Fe homeostasis. Recently, we discovered that expression of mutant HTT is associated with impaired manganese (Mn) uptake following overexposure in a striatal neuronal cell line and mouse model of HD. Here we test the hypothesis that the transferrin receptor (TfR)-mediated Fe uptake pathway is responsible for the HD-associated defects in Mn uptake. Western blot analysis showed that TfR levels are reduced in the mutant STHdhQ111/Q111 striatal cell line, whereas levels of the Fe and Mn transporter, divalent metal transporter 1 (DMT1), are unchanged. To stress the Fe transport system, we exposed mutant and wild-type cells to elevated Fe(III), which revealed a subtle impairment in net Fe uptake only at the highest Fe exposures. In contrast, the HD mutant line exhibited substantial deficits in net Mn uptake, even under basal conditions. Finally, to functionally evaluate a role for Fe transporters in the Mn uptake deficit, we examined Mn toxicity in the presence of saturating Fe(III) levels. Although Fe(III) exposure decreased Mn neurotoxicity, it did so equally for wild-type and mutant cells. Therefore, although Fe transporters contribute to Mn uptake and toxicity in the striatal cell lines, functional alterations in this pathway are insufficient to explain the strong Mn resistance phenotype of this HD cell model.",
keywords = "Huntington's disease, Iron, Manganese, Neurotoxicity, Transferrin receptor",
author = "Williams, {B. Blairanne} and Kwakye, {Gunnar F.} and Michal Wegrzynowicz and Daphne Li and Michael Aschner and Erikson, {Keith M.} and Bowman, {Aaron B.}",
year = "2010",
month = "6",
day = "13",
doi = "10.1093/toxsci/kfq174",
language = "English (US)",
volume = "117",
pages = "169--179",
journal = "Toxicological Sciences",
issn = "1096-6080",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Altered manganese homeostasis and manganese toxicity in a huntington's disease striatal cell model are not explained by defects in the iron transport system

AU - Williams, B. Blairanne

AU - Kwakye, Gunnar F.

AU - Wegrzynowicz, Michal

AU - Li, Daphne

AU - Aschner, Michael

AU - Erikson, Keith M.

AU - Bowman, Aaron B.

PY - 2010/6/13

Y1 - 2010/6/13

N2 - Expansion of a polyglutamine tract in Huntingtin (Htt) leads to the degeneration of medium spiny neurons in Huntington's disease (HD). Furthermore, the HTT gene has been functionally linked to iron (Fe) metabolism, and HD patients show alterations in brain and peripheral Fe homeostasis. Recently, we discovered that expression of mutant HTT is associated with impaired manganese (Mn) uptake following overexposure in a striatal neuronal cell line and mouse model of HD. Here we test the hypothesis that the transferrin receptor (TfR)-mediated Fe uptake pathway is responsible for the HD-associated defects in Mn uptake. Western blot analysis showed that TfR levels are reduced in the mutant STHdhQ111/Q111 striatal cell line, whereas levels of the Fe and Mn transporter, divalent metal transporter 1 (DMT1), are unchanged. To stress the Fe transport system, we exposed mutant and wild-type cells to elevated Fe(III), which revealed a subtle impairment in net Fe uptake only at the highest Fe exposures. In contrast, the HD mutant line exhibited substantial deficits in net Mn uptake, even under basal conditions. Finally, to functionally evaluate a role for Fe transporters in the Mn uptake deficit, we examined Mn toxicity in the presence of saturating Fe(III) levels. Although Fe(III) exposure decreased Mn neurotoxicity, it did so equally for wild-type and mutant cells. Therefore, although Fe transporters contribute to Mn uptake and toxicity in the striatal cell lines, functional alterations in this pathway are insufficient to explain the strong Mn resistance phenotype of this HD cell model.

AB - Expansion of a polyglutamine tract in Huntingtin (Htt) leads to the degeneration of medium spiny neurons in Huntington's disease (HD). Furthermore, the HTT gene has been functionally linked to iron (Fe) metabolism, and HD patients show alterations in brain and peripheral Fe homeostasis. Recently, we discovered that expression of mutant HTT is associated with impaired manganese (Mn) uptake following overexposure in a striatal neuronal cell line and mouse model of HD. Here we test the hypothesis that the transferrin receptor (TfR)-mediated Fe uptake pathway is responsible for the HD-associated defects in Mn uptake. Western blot analysis showed that TfR levels are reduced in the mutant STHdhQ111/Q111 striatal cell line, whereas levels of the Fe and Mn transporter, divalent metal transporter 1 (DMT1), are unchanged. To stress the Fe transport system, we exposed mutant and wild-type cells to elevated Fe(III), which revealed a subtle impairment in net Fe uptake only at the highest Fe exposures. In contrast, the HD mutant line exhibited substantial deficits in net Mn uptake, even under basal conditions. Finally, to functionally evaluate a role for Fe transporters in the Mn uptake deficit, we examined Mn toxicity in the presence of saturating Fe(III) levels. Although Fe(III) exposure decreased Mn neurotoxicity, it did so equally for wild-type and mutant cells. Therefore, although Fe transporters contribute to Mn uptake and toxicity in the striatal cell lines, functional alterations in this pathway are insufficient to explain the strong Mn resistance phenotype of this HD cell model.

KW - Huntington's disease

KW - Iron

KW - Manganese

KW - Neurotoxicity

KW - Transferrin receptor

UR - http://www.scopus.com/inward/record.url?scp=77955859930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955859930&partnerID=8YFLogxK

U2 - 10.1093/toxsci/kfq174

DO - 10.1093/toxsci/kfq174

M3 - Article

C2 - 20547568

AN - SCOPUS:77955859930

VL - 117

SP - 169

EP - 179

JO - Toxicological Sciences

JF - Toxicological Sciences

SN - 1096-6080

IS - 1

ER -